Researchers discover protein that regulates the gene expression for influential immune cells, paving a path for novel targets to treat inflammatory and allergic diseases.
A clinical trial for peanut allergy treatment has hit another milestone, with research suggesting graduated doses of peanut protein powder could help protect allergic children.
U-M researchers aim to develop a new immunotherapy that could alter the immune reactions to food. The result: extended relief from peanut allergies.
The results suggest that graduated doses of peanut protein powder could help protect against the consequences of accidental allergen exposure.